Allianz Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $103K | Buy |
|
|||||
|
2024
Q4 | $94K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $236K | Hold |
|
|||||
|
2023
Q2 | $234K | Buy |
|
|||||
|
2023
Q1 | $187K | Sell |
|
|||||
|
2022
Q4 | $532K | Sell |
|
|||||
|
2022
Q3 | $752K | Sell |
|
|||||
|
2022
Q2 | $4.71M | Buy |
|
|||||
|
2022
Q1 | $4.96M | Buy |
|
|||||
|
2021
Q4 | $3.64M | Buy |
|
|||||
|
2021
Q3 | $2.06M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $65K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $309K | Sell |
|
|||||
|
2019
Q2 | $1M | Sell |
|
|||||
|
2019
Q1 | $2.73M | Buy |
|
|||||
|
2018
Q4 | $2.17M | Sell |
|
|||||
|
2018
Q3 | $2.12M | Buy |
|
|||||
|
2018
Q2 | $1.32M | Sell |
|
|||||
|
2018
Q1 | $1.1M | Buy |
|
|||||
|
2017
Q4 | $810K | Buy |
|
|||||
|
2017
Q3 | $835K | Buy |
|
|||||
|
2017
Q2 | $654K | Sell |
|
|||||
|
2017
Q1 | $1.01M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $247K | Buy |
|